Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lindsay S Keir

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 9, 2016
Complement and the kidney in the setting of Shiga-toxin hemolytic uremic syndrome, organ transplantation, and C3 glomerulonephritisLindsay S Keir, Craig B Langman
Pediatric Nephrology (Berlin, Germany)|July 12, 2013
Current evidence for the role of complement in the pathogenesis of Shiga toxin haemolytic uraemic syndromeLindsay S Keir, Moin A Saleem
Drug Design, Development and Therapy|August 14, 2012
Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapiesLindsay S Keir, Stephen D Marks, Jon Jin Kim
Nephron|February 28, 2015
Generating conditionally immortalised podocyte cell lines from wild-type miceLindsay S Keir, Rachel Firth, Carl May, et al.
Frontiers in Immunology|September 14, 2020
Podocytes Produce and Secrete Functional Complement C3 and Complement Factor HAnne K Mühlig, Lindsay S Keir, Jana C Abt, et al.
Journal of the American Society of Nephrology : JASN|June 7, 2014
Loss of the podocyte-expressed transcription factor Tcf21/Pod1 results in podocyte differentiation defects and FSGSYoshiro Maezawa, Tuncer Onay, Rizaldy P Scott, et al.
The Journal of Clinical Investigation|December 6, 2016
VEGF regulates local inhibitory complement proteins in the eye and kidneyLindsay S Keir, Rachel Firth, Lyndsey Aponik, et al.
Med (New York, N.Y.)|October 20, 2023
Shiga toxin targets the podocyte causing hemolytic uremic syndrome through endothelial complement activationEmily E Bowen, Jennifer A Hurcombe, Fern Barrington, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 9, 2016
Complement and the kidney in the setting of Shiga-toxin hemolytic uremic syndrome, organ transplantation, and C3 glomerulonephritisLindsay S Keir, Craig B Langman
Pediatric Nephrology (Berlin, Germany)|July 12, 2013
Current evidence for the role of complement in the pathogenesis of Shiga toxin haemolytic uraemic syndromeLindsay S Keir, Moin A Saleem
Drug Design, Development and Therapy|August 14, 2012
Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapiesLindsay S Keir, Stephen D Marks, Jon Jin Kim
Nephron|February 28, 2015
Generating conditionally immortalised podocyte cell lines from wild-type miceLindsay S Keir, Rachel Firth, Carl May, et al.
Frontiers in Immunology|September 14, 2020
Podocytes Produce and Secrete Functional Complement C3 and Complement Factor HAnne K Mühlig, Lindsay S Keir, Jana C Abt, et al.
Journal of the American Society of Nephrology : JASN|June 7, 2014
Loss of the podocyte-expressed transcription factor Tcf21/Pod1 results in podocyte differentiation defects and FSGSYoshiro Maezawa, Tuncer Onay, Rizaldy P Scott, et al.
The Journal of Clinical Investigation|December 6, 2016
VEGF regulates local inhibitory complement proteins in the eye and kidneyLindsay S Keir, Rachel Firth, Lyndsey Aponik, et al.
Med (New York, N.Y.)|October 20, 2023
Shiga toxin targets the podocyte causing hemolytic uremic syndrome through endothelial complement activationEmily E Bowen, Jennifer A Hurcombe, Fern Barrington, et al.
Pageof 1